理邦儀器(300206.SZ):目前心電監測產品主要服務於醫療機構
格隆匯9月6日丨理邦儀器(300206.SZ)在投資者互動平台表示,理邦在心電監測技術方面確實有深厚的積累,並且已經建立了全面的心電診斷業務體系,包括靜態心電、運動心電和動態心電/血壓監測,同時也提供完善的心電網絡解決方案。目前,公司的心電監測產品主要服務於醫療機構。當然,公司也看到了家用醫療器械市場的巨大潛力,並認為這是未來發展的關鍵方向之一。因此,公司也在積極佈局這一領域,並計劃根據市場需求和技術發展,適時推進家用心電監測產品項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.